The Roots Analysis team is putting in its best effort to offer our clients / readers a reliable source of information, regarding how the pharmaceutical and biotech sectors are coping in the midst of the COVID-19 pandemic. Our intention is to generate realistic insights, based on a variety of factors, which are anticipated to influence both prevalent and future market dynamics. Reach out to us for any help.

AR / VR based Healthcare Digital Marketing Service Providers Market, 2020-2030

  • Lowest Price Guaranteed From USD 4,899

  • Published
    June 2020

  • Pages
    190

  • View Count
    1759

Example Insights

AR-VR-based-Healthcare-Digital-Marketing-Context AR-VR-based-Healthcare-Digital-Marketing-Service-Providers AR-VR-based-Healthcare-Digital-Marketing-Distribution-by-technology
AR-VR-based-Healthcare-Digital-Marketing-Geographical-distribution AR-VR-based-Healthcare-Digital-Marketing-Company-Competitiveness-Analysis AR-VR-based-Healthcare-Digital-Marketing-Competitive-Benchmarking
AR-VR-based-Healthcare-Digital-Marketing-Various-therapy-developers AR-VR-based-Healthcare-Digital-Marketing-Market-Opportunity-Assessment  

 

Overview

Advent of smartphones coupled to the easy accessibility of information on the internet, has rendered it crucial for companies to establish a digital presence. As opposed to traditional strategies, digital marketing is not only cost effective but offers several ancillary benefits, such as targeted outreach and data driven output. In fact, a recent study stated that digital advertising is expected to account for around 50% of the overall global advertisement spend by 2021. However, the adoption of digital marketing solutions in the pharmaceutical industry has been stymied owing to various regulatory restrictions; presently, the healthcare industry accounts for only 2% of the US digital ad spend. Despite this, it is encouraging to note that over 85% of the patients in the US have access to digital and online resources to assist them in making informed healthcare decisions. Further, most of the individuals claim to use healthcare apps to track their diagnosed condition; therefore, large amount of data is available for studying the trends associated with a particular indication. In addition, a recent study concluded that physicians are actively using different digital and social media platforms in order to make healthcare related decisions, such as prescription of a particular drug. The aforementioned factors indicate that there is a growing need for pharma companies to increase their digital presence, through activity on social media and participation in online forums, in order to widen their reach to target the relevant customer segments. 

Augmented reality (AR) and virtual reality (VR) technologies offer several advantages; examples include allowing patients to have a deeper understanding of their condition, ensuring effective communication by providing immersive experiences, assisting sales representatives to give quick and appealing product illustrations, and enabling individuals to assess the impact of various treatment options, through product demonstrations or use of virtual clinics. Estimates suggest that more than 60% of the consumers feel more engaged with a brand that offers them a VR experience; likewise, a similar percentage of US based physicians are reported to be inclined to use such solutions for education and training purposes. The growing applications of AR / VR in the healthcare marketing sector have compelled various big pharma players to invest in such novel solutions and innovative strategies. We believe that stakeholders in the pharma industry that choose to adopt such technologies, in order to form engaging relationships with their consumers and ensure brand loyalty, are likely to be able to distinguish themselves from other industry stakeholders.

Scope of the Report

The ‘AR / VR based Healthcare Digital Marketing Service Providers, 2020-2030’ report features an extensive study of the current market landscape and future opportunities associated with the AR / VR based digital marketing industry in the healthcare domain. Amongst other elements, the report features:

  • A review of the current market landscape of companies offering AR / VR based digital marketing services, featuring type of technology (AR, VR and MR), AR / VR specific services (video / content generation, website development, mobile application development and game development), additional digital marketing services (consulting, content marketing, customer relationship management, data analytics, marketing automation, product branding, quality assurance, SEO, SEM, social media marketing and training), information on the year of establishment, company size and location of headquarters.  
  • An insightful 2X2 representation, highlighting the competitiveness analysis of digital marketing companies, taking into consideration supplier power (based on company size) and service strength (based on strength of service portfolio) of the companies.
  • Elaborate profiles of prominent digital marketing companies, featuring a brief overview of the company, its financial information (if available), recent developments and an informed future outlook.
  • An analysis highlighting the potential strategic partners segregated on the basis of their likelihood of entering into collaboration with digital marketing companies. The analysis takes into consideration multiple relevant parameters, such as number of trials, therapeutic area, geographical footprint and company size.
  • An analysis of various AR / VR based digital marketing initiatives of big pharma players (shortlisted based on extent of activity in this domain), based on multiple parameters, such as the year of initiative, type of initiative, type of application area and type of solution. In addition, leading players and leading partners have been highlighted based on the number of initiatives.
  • A case study on recent use cases, wherein various digital marketing strategies have been adopted by pharmaceutical / healthcare players, highlighting different business needs of such players and key takeaways of the solutions provided by the digital marketing companies.

One of the key objectives of the report was to understand the primary growth drivers and estimate the future opportunity within the market. Based on several parameters, such as digital marketing spend within the pharma industry, extent of adoption of AR / VR technologies and expected annual growth rate, we have provided an informed estimate of the likely evolution of the market, in the mid to long term, for the period 2020-2030. The chapter features the likely distribution of the future opportunity across [A] type of technology (AR, VR and MR), [B] type of product (Hardware and Software), [C] end-user (Small and Mid-sized Pharma Companies, and Large Pharma Companies) and [D] key geographical regions (North America, Europe, Asia-Pacific and rest of the world).

In order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, portraying the conservative, base and optimistic tracks of the market’s evolution. The opinions and insights presented in this study were influenced by discussions conducted with multiple stakeholders in this domain. In addition, the report features detailed transcripts of interviews held with the following individuals (in alphabetical order of company names):

  • Dhananjay Arora (Founder and CEO, Kwebmaker) 
  • Pritam Sahu (Director, Unanimity Information & Technology) 

All actual figures have been sourced and analyzed from publicly available information forums. Financial figures mentioned in this report are in USD, unless otherwise specified.

Contents

Chapter Outlines

Chapter 2 is an executive summary of the insights captured in our research. It offers a high-level view on the likely evolution of the AR / VR based digital marketing industry in the healthcare domain in the mid to long term.

Chapter 3 provides an overview of the various challenges in the current pharmaceutical marketing domain, as well as the rising popularity of digital marketing channels and various applications of AR / VR technologies in the pharmaceutical industry. Further, the chapter includes an overview of different approaches, through which AR / VR based solutions can be used in pharma marketing. It also includes a discussion on the challenges and future perspectives of these AR / VR technologies.

Chapter 4 provides an overview of the current market landscape of companies offering AR / VR based digital marketing services, featuring type of technology (AR, VR and MR), AR / VR specific services (video / content generation, website development, mobile application development and game development), additional digital marketing services (consulting, content marketing, customer relationship management, data analytics, marketing automation, product branding, quality assurance, SEO, SEM, social media marketing and training), information on the year of establishment, company size and location of headquarters.  

Chapter 5 provides a highlighting the competitiveness analysis of digital marketing companies, taking into consideration supplier power (based on company size) and service strength (based on strength of service portfolio) of the companies.

Chapter 6 includes detailed profiles of prominent digital marketing companies, featuring a brief overview of the company, its financial information (if available), recent developments and an informed future outlook.

Chapter 7 features a detailed analysis, highlighting the potential strategic partners segregated on the basis of their likelihood of entering into collaboration with digital marketing companies. The analysis takes into consideration multiple relevant parameters, such as number of trials, therapeutic area, geographical footprint and company size.

Chapter 8 provides various AR / VR based digital marketing initiatives of big pharma players (shortlisted based on extent of activity in this domain), based on multiple parameters, such as the year of initiative, type of initiative, type of application area and type of solution. In addition, leading players and leading partners have been highlighted based on the number of initiatives.

Chapter 9 presents a case study on recent use cases wherein various digital marketing strategies have been adopted by pharmaceutical / healthcare players, highlighting different business needs of such players and key takeaways of the solution provided by the digital marketing companies.

Chapter 10 presents a detailed market forecast, highlighting the future potential of the AR / VR based digital marketing industry in the healthcare domain, for the period 2020-2030. The chapter features the likely distribution of the opportunity across [A] type of technology (AR, VR and MR) [B] type of product (Hardware and Software), [C] end-user (Small and Mid-sized Pharma Companies, and Large Pharma Companies) and [D] key geographical regions (North America, Europe, Asia-Pacific and rest of the world).

Chapter 11 summarizes the entire report. It presents a list of key takeaways and offers our independent opinion on the current market scenario. Further, it summarizes the various evolutionary trends that are likely to influence the future of this market.

Chapter 12 is a collection of executive insights of the discussions that were held with various key stakeholders in this market. The chapter provides a brief overview of the companies and details of interviews held with Dhananjay Arora (Founder and CEO, Kwebmaker) and Pritam Sahu (Director, Unanimity Information & Technology)

Chapter 13 is an appendix, which provides tabulated data and numbers for all the figures included in the report.

Chapter 14 is an appendix, which contains the list of companies and organizations mentioned in the report.

Table Of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Key Challenges in Pharmaceutical Marketing
3.2.1. Need for Product Differentiation
3.2.2. Growing Demand for Patient Centric Healthcare
3.2.3. Lack of Standard Performance Metrics
3.2.4. Need for Scientific Communication

3.3. Importance of Digital Marketing
3.4. Popular Digital Marketing Strategies
3.4.1. Social Media Marketing
3.4.2. Content Marketing Strategy
3.4.3. Marketing Automation
3.4.4. Search Engine Optimization and Marketing
3.4.5. Artificial Intelligence based Marketing

3.5. Use of Augmented Reality and Virtual Reality (AR / VR) in Pharmaceutical Digital Marketing
3.6. Growth Constraints in AR / VR Industry
3.7. Future Perspectives

4. AR / VR BASED HEALTHCARE DIGITAL MARKETING COMPANIES: CURRENT MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Digital Marketing in Pharmaceutical Industry: Overall Market 
4.2.1. Analysis by Type of Technology
4.2.2. Analysis by AR / VR based Services Offered
4.2.3. Analysis by Type of Digital Marketing Services Offered
4.2.4. Analysis by Secondary Marketing Services Offered
4.2.5. Analysis by Year of Establishment
4.2.6. Analysis by Company Size
4.2.7. Analysis by Geographical Location

5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Methodology and Key Parameters
5.2.1. Competitiveness Analysis: AR / VR based Digital Marketing Service Providers based in North America
5.2.2. Competitiveness Analysis: AR / VR based Digital Marketing Service Providers based in Europe
5.2.3. Competitiveness Analysis: AR / VR based Digital Marketing Service Providers based in Asia-Pacific

6. COMPANY PROFILES
6.1. Chapter Overview
6.2. ARworks
6.2.1. Company Overview
6.2.2. Recent Developments and Future Outlook

6.3. CG Life
6.3.1. Company Overview
6.3.2. Recent Developments and Future Outlook

6.4. CubeZoo
6.4.1. Company Overview
6.4.2. Recent Developments and Future Outlook

6. 5. Impact XM
6. 5.1. Company Overview
6. 5.2. Recent Developments and Future Outlook

6.6. INVIVO Communications
6.6.1. Company overview
6.6.2. Recent Developments and Future Outlook

6.7. Mindgrub
6.7.1. Company Overview
6.7.2. Recent Developments and Future Outlook

6.8. Mirum 
6.8.1. Company Overview
6.8.2. Recent Developments and Future Outlook

6.9. PIXACORE
6.9.1. Company Overview
6.9.2. Recent Developments and Future Outlook

6.10. Quast Media
6.10.1. Company Overview
6.10.2. Recent Developments and Future Outlook

6.11. Random42
6.11.1. Company Overview
6.11.2. Recent Developments and Future Outlook

6.12. Tipping Point Media
6.12.1. Company Overview
6.12.2. Recent Developments and Future Outlook

6.13. vStream
6.13.1. Company Overview
6.13.2. Recent Developments and Future Outlook

7. POTENTIAL STRATEGIC PARTNERS
7.1. Chapter Overview
7.2. Scope and Methodology
7.3. Potential Strategic Partners for Digital Marketing Companies 
7.3.1. Most Likely Partners
7.3.2. Likely Partners
7.3.3. Less Likely Partners
7.3.4. Least Likely Partners

8. DIGITAL MARKETING RELATED INITIATIVES OF BIG PHARMA PLAYERS
8.1. Chapter Overview
8.1.1. Analysis by Year
8.1.2. Analysis by Type of Initiative
8.1.3. Analysis by Type of Application Area
8.1.4. Analysis by Type of Solution
8.1.5. Leading Players: Analysis by Number of Initiatives
8.1.6. Leading Partners: Analysis by Number of Initiatives

9. CASE STUDY
9.1. Chapter Overview
9.2. Narola Infotech for Zocular
9.2.1. Narola Infotech
9.2.2. Zocular
9.2.3. Business Needs
9.2.4. Objectives Achieved and Solutions Provided

9.3. Viscira for Actelion
9.3.1. Viscira
9.3.2. Actelion
9.3.3. Business Needs
9.3.4. Objectives Achieved and Solutions Provided

9.4. SoftCover VR for LifeLabs
9.4.1. SoftCover VR
9.4.2. LifeLabs
9.4.3. Business Needs
9.4.4. Objectives Achieved and Solutions Provided

9.5. Virtual Reality Ireland for MISA
9.5.1. Virtual Reality Ireland
9.5.2. MISA
9.5.3. Business Needs
9.5.4. Objectives Achieved and Solutions Provided

9.6. ViitorCloud for vCura
9.6.1. ViitorCloud
9.6.2. vCura
9.6.3. Business Needs
9.6.4. Objectives Achieved and Solutions Provided

9.7. Kwebmaker for Lilavati Hospital
9.7.1. Kwebmaker
9.7.2. Lilavati Hospital
9.7.3. Business Needs
9.7.4. Objectives Achieved and Solutions Provided

9.8. Intermind for My Health Meter
9.8.1. Intermind
9.8.2. My Health Meter
9.8.3. Business Needs
9.8.4. Objectives Achieved and Solutions Provided

9.9. VR Vision for Providence Healthcare
9.9.1. VR Vision
9.9.2. Providence Healthcare
9.9.3. Business Needs
9.9.4. Objectives Achieved and Solutions Provided

9.10. CitrusBits for Zoetis
9.10.1. CitrusBits
9.10.2. Zoetis
9.10.3. Business Needs
9.10.4. Objectives Achieved and Solutions Provided

10. MARKET FORECAST
10.1. Chapter Overview
10.2. Forecast Methodology and Key Assumptions
10.3. Overall AR / VR based Digital Marketing Opportunity in Healthcare Industry, 2020-2030
10.4. AR / VR based Digital Marketing Opportunity in Healthcare Industry: Distribution by Type of Technology, 2020 and 2030
10.5. AR / VR based Digital Marketing Opportunity in Healthcare Industry: Distribution by Product, 2020 and 2030
10.6. AR / VR based Digital Marketing Opportunity in Healthcare Industry: Distribution by End-User, 2020 and 2030
10.7. AR / VR based Digital Marketing Opportunity in Healthcare Industry: Distribution by Key Geographical Regions, 2020 and 2030
10.7.1. AR / VR based Digital Marketing Opportunity in Healthcare Industry in North America, 2020-2030
10.7.1.1. AR / VR based Digital Marketing Opportunity in Healthcare Industry in North America: Distribution by Type of Technology, 2020 and 2030
10.7.1.1.1. AR / VR based Digital Marketing Opportunity in Healthcare Industry in North America: Share of AR based Services, 2020 and 2030
10.7.1.1.2. AR / VR based Digital Marketing Opportunity in Healthcare Industry in North America:Share of VR based Services, 2020-2030
10.7.1.1.3. AR / VR based Digital Marketing Opportunity in Healthcare Industry in North America: Share of Mixed Reality (MR) based Services, 2020 and 2030
10.7.1.2. AR / VR based Digital Marketing Opportunity in Healthcare Industry in North America: Distribution by Type of Product, 2020 and 2030
10.7.1.2.1. AR / VR based Digital Marketing Opportunity in Healthcare Industry in North America: Share of Hardware Products, 2020-2030
10.7.1.2.2. AR / VR based Digital Marketing Opportunity in Healthcare Industry in North America: Share of Software Products, 2020-2030

10.7.2. AR / VR based Digital Marketing Opportunity in Healthcare Industry in Europe, 2020-2030
10.7.2.1. AR / VR based Digital Marketing Opportunity in Healthcare Industry in Europe: Distribution by Type of Technology, 2020-2030
10.7.2.1.1. AR / VR based Digital Marketing Opportunity in Healthcare Industry in Europe: Share of AR based Services, 2020-2030
10.7.2.1.2. AR / VR based Digital Marketing Opportunity in Healthcare Industry in Europe: Share of VR based Services, 2020-2030
10.7.2.1.3. AR / VR based Digital Marketing Opportunity in Healthcare Industry in Europe: Share of AR based Services, 2020-2030
10.7.2.2. AR / VR based Digital Marketing Opportunity in Healthcare Industry in Europe: Distribution by Type of Product, 2020 and 2030
10.7.2.2.1. AR / VR based Digital Marketing Opportunity in Healthcare Industry in Europe: share of Hardware Products, 2020-2030
10.7.2.2.2. AR / VR based Digital Marketing Opportunity in Healthcare Industry in Europe: Share of Software Products, 2020-2030
10.7.3. AR / VR based Digital Marketing Opportunity in Healthcare Industry in Asia-Pacific, 2020-2030
10.7.3.1. AR / VR based Digital Marketing Opportunity in Healthcare Industry in Asia-Pacific: Distribution by Type of Technology, 2020 and 2030
10.7.3.1.1. AR / VR based Digital Marketing Opportunity in Healthcare Industry in Asia-Pacific: Share of AR based Services, 2020 and 2030
10.7.3.1.2. AR / VR based Digital Marketing Opportunity in Healthcare Industry in Asia-Pacific: Share of VR based Services, 2020-2030
10.7.3.1.3. AR / VR based Digital Marketing Opportunity in Healthcare Industry in Asia-Pacific: Share of MR based Services, 2020 and 2030
10.7.3.2. AR / VR based Digital Marketing Opportunity in Healthcare Industry in Asia-Pacific: Distribution by Type of Product, 2020 and 2030
10.7.3.2.1. AR / VR based Digital Marketing Opportunity in Healthcare Industry in Asia-Pacific: Share of Hardware Products, 2020-2030
10.7.3.2.2. AR / VR based Digital Marketing Opportunity in Healthcare Industry in Asia-Pacific: Share of Software Products, 2020-2030

10.7.1. AR / VR based Digital Marketing Opportunity in Healthcare Industry in Rest of the World, 2020-2030
10.7.1.1. AR / VR based Digital Marketing Opportunity in Healthcare Industry in Rest of the World: Distribution by Type of Technology, 2020 and 2030
10.7.1.1.1. AR / VR based Digital Marketing Opportunity in Healthcare Industry in Rest of the World: Share of AR based Services, 2020 and 2030
10.7.1.1.2. AR / VR based Digital Marketing Opportunity in Healthcare Industry in Rest of the World: Share of VR based Services. 2020-2030
10.7.1.1.3. AR / VR based Digital Marketing Opportunity in Healthcare Industry in Rest of the World: Share of MR based Services, 2020 and 2030
10.7.1.2. AR / VR based Digital Marketing Opportunity in Healthcare Industry in Rest of the World: Distribution by Type of Product, 2020 and 2030
10.7.1.2.1. AR / VR based Digital Marketing Opportunity in Healthcare Industry in Rest of the World: Share of Hardware Products, 2020-2030
10.7.1.2.2. AR / VR based Digital Marketing Opportunity in Healthcare Industry in Rest of the World: Share of Software Products, 2020-2030

11. EXECUTIVE INSIGHTS
11.1. Chapter Overview
11.2. Unanimity Information & Technology
11.2.1. Interview Transcript: Pritam Sahu, Director, Unanimity Information & Technology

11.3. Kwebmaker
11.3.1. Interview Transcript: Dhananjay Arora, Founder and CEO, Kwebmaker

12. CONCLUSION

13. APPENDIX 1: TABULATED DATA

14. APPENDIX 2: LIST OF COMPANIES AND ORGANISATIONS

List Of Figures

Figure 3.1 Digital Advertising Spend: Distribution by Type of Industry
Figure 3.2 Challenges in Pharmaceutical Marketing
Figure 3.3 Popular Digital Marketing Strategies
Figure 3.4 Social Media Marketing Channels
Figure 3.5 Search Engine Ranking Factors
Figure 3.6 Benefits of AI in Digital Marketing
Figure 4.1 AR / VR based Digital Marketing Service Providers: Distribution by Type of Technology
Figure 4.2 AR / VR based Digital Marketing Service Providers: Distribution by AR / VR based Services Offered
Figure 4.3 AR / VR based Digital Marketing Service Providers: Distribution by Type of Digital Marketing Services Offered
Figure 4.4 AR / VR based Digital Marketing Service Providers: Distribution by Secondary Marketing Services Offered
Figure 4.5 AR / VR based Digital Marketing Service Providers: Distribution by Year of Establishment.
Figure 4.6 AR / VR based Digital Marketing Service Providers: Distribution by Company Size
Figure 4.7 AR / VR based Digital Marketing Service Providers: Distribution by Geographical Location
Figure 5.1 Competitiveness Analysis: AR / VR based Digital Marketing Service Providers based in North America
Figure 5.2 Competitiveness Analysis: AR / VR based Digital Marketing Service Providers based in Europe
Figure 5.3 Competitiveness Analysis: AR / VR based Digital Marketing Service Providers based in Asia-Pacific
Figure 8.1 Big Pharma Initiatives: Distribution by Year
Figure 8.2 Big Pharma Initiatives: Distribution by Type of Initiative
Figure 8.3 Big Pharma Initiatives: Distribution by Type of Application Area
Figure 8.4 Big Pharma Initiatives: Heat Map Analysis by Type of Application Area
Figure 8.5 Big Pharma Initiatives: Distribution by Type of Solution
Figure 8.6 Big Pharma Initiatives: Heat Map Analysis by Type of Solution
Figure 8.7 Leading Players: Distribution by Number of Initiatives
Figure 8.8 Leading Partners: Distribution by Number of Initiatives
Figure 10.1 Overall AR / VR based Digital Marketing Opportunity in Healthcare Industry, 2020-2030 (USD Billion)
Figure 10.2 AR / VR based Digital Marketing Opportunity in Healthcare Industry: Distribution by Type of Technology, 2020 and 2030 (USD Billion)
Figure 10.3 AR / VR based Digital Marketing Opportunity in Healthcare Industry: Distribution by Product, 2020 and 2030 (USD Billion)
Figure 10.4 AR / VR based Digital Marketing Opportunity in Healthcare Industry: Distribution by End-User, 2020 and 2030 (USD Billion)
Figure 10.5 AR / VR based Digital Marketing Opportunity in Healthcare Industry: Distribution by Key Geographical Region, 2020 and 2030 (USD Billion)
Figure 10.6 AR / VR based Digital Marketing Opportunity in Healthcare Industry in North America, 2020-2030 (USD Billion)
Figure 10.7 AR / VR based Digital Marketing Opportunity in Healthcare Industry in North  America: Share of AR based Services, 2020-2030 (USD Billion)
Figure 10.8 AR / VR based Digital Marketing Opportunity in Healthcare Industry in North America: Share of VR based Services, 2020-2030 (USD Billion)
Figure 10.9 AR / VR based Digital Marketing Opportunity in Healthcare Industry in North America: Share of MR based Services, 2020-2030 (USD Billion)
Figure 10.10 AR / VR based Digital Marketing Opportunity in Healthcare Industry in North America: Share of Hardware Products, 2020-2030 (USD Billion)
Figure 10.11 AR / VR based Digital Marketing Opportunity in Healthcare Industry in North America: Share of Software Products, 2020-2030 (USD Billion)
Figure 10.12 AR / VR based Digital Marketing Opportunity in Healthcare Industry in Europe, 2020-2030 (USD Billion)
Figure 10.13 AR / VR based Digital Marketing Opportunity in Healthcare Industry in Europe: Share of AR based Services, 2020-2030 (USD Billion)
Figure 10.14 AR / VR based Digital Marketing Opportunity in Healthcare Industry in Europe: Share of VR based Services, 2020-2030 (USD Billion)
Figure 10.15 AR / VR based Digital Marketing Opportunity in Healthcare Industry in Europe: Share of MR based Services, 2020-2030 (USD Billion)
Figure 10.16 AR / VR based Digital Marketing Opportunity in Healthcare Industry in Europe: Share of Hardware Products, 2020-2030 (USD Billion)
Figure 10.17 AR / VR based Digital Marketing Opportunity in Healthcare Industry in Europe: Share of Software Products, 2020-2030 (USD Billion)
Figure 10.18 AR / VR based Digital Marketing Opportunity in Healthcare Industry in Asia Pacific, 2020-2030 (USD Billion)
Figure 10.19 AR / VR based Digital Marketing Opportunity in Healthcare Industry in Asia Pacific: Share of AR based Services, 2020-2030 (USD Billion)
Figure 10.20 AR / VR based Digital Marketing Opportunity in Healthcare Industry in Asia Pacific: Share of VR based Services, 2020-2030 (USD Billion)
Figure 10.21 AR / VR based Digital Marketing Opportunity in Healthcare Industry in Asia Pacific: Share of MR based Services, 2020-2030 (USD Billion)
Figure 10.22 AR / VR based Digital Marketing Opportunity in Healthcare Industry in Asia Pacific: Share of Hardware Products, 2020-2030 (USD Billion)
Figure 10.23 AR / VR based Digital Marketing Opportunity in Healthcare Industry in Asia Pacific: Share of Software Products, 2020-2030 (USD Billion)

List Of Tables

Table 4.1 AR / VR based Digital Marketing Service Providers: Information on Type of Technology and Affiliated Services Offered
Table 4.2 AR / VR based Digital Marketing Service Providers: Information on Type of Digital Marketing Services Offered
Table 4.3 AR / VR based Digital Marketing Service Providers: Information on Secondary Marketing Services Offered
Table 4.4 AR / VR based Digital Marketing Service Providers: List of Companies
Table 6.1 ARworks: Company Snapshot
Table 6.2 CG Life: Company Snapshot
Table 6.3 CG Life: Recent Developments and Future Outlook
Table 6.4 CubeZoo: Company Snapshot
Table 6.5 Impact XM: Company Snapshot
Table 6.6 Impact XM: Recent Developments and Future Outlook
Table 6.7 INVIVO Communications: Company Snapshot
Table 6.8 INVIVO Communications: Recent Developments and Future Outlook
Table 6.9 Mindgrub: Company Snapshot
Table 6.10 Mindgrub: Recent Developments and Future Outlook
Table 6.11 Mirum: Company Snapshot
Table 6.12 Mirum: Recent Developments and Future Outlook
Table 6.13 PIXACORE: Company Snapshot
Table 6.14 PIXACORE: Recent Developments and Future Outlook
Table 6.15 Quast Media: Company Snapshot
Table 6.16 Random42: Company Snapshot
Table 6.17 Rando m42: Recent Developments and Future Outlook
Table 6.18 Tipping Point Media: Company Snapshot
Table 6.19 vStream: Company Snapshot
Table 6.20 vStream: Recent Developments and Future Outlook
Table 7.1 Most Likely Partners
Table 7.2 Likely Partners
Table 7.3 Less Likely Partners
Table 7.4 Least Likely Partners
Table 13.1 AR / VR based Digital Marketing Service Providers: Distribution by Type of Technology
Table 13.2 AR / VR based Digital Marketing Service Providers: Distribution by AR / VR based Services Offered
Table 13.3 AR / VR based Digital Marketing Service Providers: Distribution by Digital Marketing Servises Offered
Table 13.4 AR / VR based Digital Marketing Service Providers: Distribution by Secondary Marketing Services Offered
Table 13.5 AR / VR based Digital Marketing Service Providers: Distribution by Year of Establishment
Table 13.6 AR / VR based Digital Marketing Service Providers: Distribution by Company Size
Table 13.7 AR / VR based Digital Marketing Service Providers: Distribution by Geographical Location
Table 13.8 Big Pharma Initiatives: Distribution by Year
Table 13.9 Big Pharma Initiatives: Distribution by Type of Initiative
Table 13.10 Big Pharma Initiatives: Distribution by Type of Application Area
Table 13.11 Big Pharma Initiatives: Distribution by Type of Solution
Table 13.12 Leading Players: Analysis by Number of Initiatives
Table 13.13 Leading Partners: Analysis by Number of Initiatives
Table 13.14 Overall AR / VR based Digital Marketing Opportunity in Healthcare Industry, 2020-2030 (USD Billion)
Table 13.15 AR / VR based Digital Marketing Opportunity in Healthcare Industry: Distribution by Type of Technology, 2020 and 2030 (USD Billion)
Table 13.16 AR / VR based Digital Marketing Opportunity in Healthcare Industry: Distribution by Product, 2020 and 2030 (USD Billion)
Table 13.17 AR / VR based Digital Marketing Opportunity in Healthcare Industry: Distribution by End-User, 2020 and 2030 (USD Billion)
Table 13.18 AR / VR based Digital Marketing Opportunity in Healthcare Industry: Distribution by Key Geographical Region, 2020 and 2030 (USD Billion)
Table 13.19 AR / VR based Digital Marketing Opportunity in Healthcare Industry in North America, 2020-2030 (USD Billion)
Table 13.20 AR / VR based Digital Marketing Opportunity in Healthcare Industry: in North America: Share of AR based Services, 2020-2030 (USD Billion)
Table 13.21 AR / VR based Digital Marketing Opportunity in Healthcare Industry in North America: Share of VR based Services, 2020-2030 (USD Billion)
Table 13.22 AR / VR based Digital Marketing Opportunity in Healthcare Industry in North America: Share of MR based Services, 2020-2030 (USD Billion)
Table 13.23 AR / VR based Digital Marketing Opportunity in Healthcare Industry in North America: Share of Hardware Products, 2020-2030 (USD Billion)
Table 13.24 AR / VR based Digital Marketing Opportunity in Healthcare Industry in North America: Share of Software Products, 2020-2030 (USD Billion)
Table 13.25 AR / VR based Digital Marketing Opportunity in Healthcare Industry in Europe, 2020-2030 (USD Billion)
Table 13.26 AR / VR based Digital Marketing Opportunity in Healthcare Industry: in Europe: Share of AR based Services, 2020-2030 (USD Billion)
Table 13.27 AR / VR based Digital Marketing Opportunity in Healthcare Industry in Europe: Share of VR based Services, 2020-2030 (USD Billion)
Table 13.28 AR / VR based Digital Marketing Opportunity in Healthcare Industry in Europe: Share of MR based Services, 2020-2030 (USD Billion)
Table 13.29 AR / VR based Digital Marketing Opportunity in Healthcare Industry in Europe: Share of Hardware Products, 2020-2030 (USD Billion)
Table 13.30 AR / VR based Digital Marketing Opportunity in Healthcare Industry in Europe: Share of Software Products, 2020-2030 (USD Billion)
Table 13.31 AR / VR based Digital Marketing Opportunity in Healthcare Industry in Asia-Pacific, 2020-2030 (USD Billion)
Table 13.32 AR / VR based Digital Marketing Opportunity in Healthcare Industry: in Asia-Pacific: Share of AR based Services, 2020-2030 (USD Billion)
Table 13.33 AR / VR based Digital Marketing Opportunity in Healthcare Industry in Asia-Pacific: Share of VR based Services, 2020-2030 (USD Billion)
Table 13.34 AR / VR based Digital Marketing Opportunity in Healthcare Industry in Asia-Pacific: Share of MR based Services, 2020-2030 (USD Billion)
Table 13.35 AR / VR based Digital Marketing Opportunity in Healthcare Industry in Asia-Pacific: Share of Hardware Products, 2020-2030 (USD Billion)
Table 13.36 AR / VR based Digital Marketing Opportunity in Healthcare Industry in Asia-Pacific: Share of Software Products, 2020-2030 (USD Billion)
Table 13.37 AR / VR based Digital Marketing Opportunity in Healthcare Industry in Rest of the World, 2020-2030 (USD Billion)
Table 13.38 AR / VR based Digital Marketing Opportunity in Healthcare Industry: in Rest of the World: Share of AR based Services, 2020-2030 (USD Billion)
Table 13.39 AR / VR based Digital Marketing Opportunity in Healthcare Industry in Rest of the World: Share of VR based Services, 2020-2030 (USD Billion)
Table 13.40 AR / VR based Digital Marketing Opportunity in Healthcare Industry in Rest of the World: Share of MR based Services, 2020-2030 (USD Billion)
Table 13.41 AR / VR based Digital Marketing Opportunity in Healthcare Industry in Rest of the World: Share of Hardware Products, 2020-2030 (USD Billion)
Table 13.42 AR / VR based Digital Marketing Opportunity in Healthcare Industry in Rest of the World: Share of Software Products, 2020-2030 (USD Billion)

Listed Companies

The following companies and organizations have been mentioned in the report.

  1. [x]cube LABS
  2. 3TI Solutions
  3. 4Experience
  4. 4D Pharma
  5. A101
  6. A2 Healthcare Taiwan
  7. A2 VR
  8. AbbVie
  9. Abivax
  10. Acceleron Pharma
  11. Acerta Pharma
  12. Achillion Pharmaceuticals
  13. Aclaris Therapeutics
  14. Acodez 
  15. Actelion
  16. ADC Therapeutics
  17. ADSMN Interactive
  18. Aduro Biotech
  19. Agendia
  20. Agenus
  21. AGILE Infoways 
  22. Agios Pharmaceuticals
  23. AIO-Studien
  24. Akari Therapeutics
  25. Akeso Pharmaceuticals
  26. Alfasigma
  27. Alkahest
  28. Allakos
  29. Allergan
  30. Alnylam Pharmaceuticals
  31. Altor BioScience
  32. Amarex Clinical Research
  33. Amazon Web Services
  34. Amgen
  35. Amplyx Pharmaceuticals
  36. AnaptysBio
  37. Anavex Australia
  38. AnewPharma
  39. Antengene
  40. Apexigen
  41. Apices Soluciones
  42. Appingine 
  43. Appnings Software Solutions
  44. AppsChopper
  45. Aprea Therapeutics
  46. Aptinyx
  47. Aravive
  48. Arbeitsgemeinschaft medikamentöse Tumortherapie
  49. Arccus
  50. Arcutis Biotherapeutics
  51. Arena Pharmaceuticals
  52. argenx
  53. Array BioPharma
  54. Arrowhead Pharmaceuticals
  55. ARworks 
  56. Assaf Harofeh Medical Center
  57. Astellas Pharma
  58. Astex Pharmaceuticals
  59. AstraZeneca
  60. Atlantic Exhibits
  61. Atrium Health
  62. Audentes Therapeutics
  63. Augmentastic 
  64. Augmented Scalla Matta
  65. Augmently
  66. Aurora Pharmaceutical 
  67. Autolus
  68. Auxano Global Services
  69. AVEO Pharmaceuticals
  70. Azura Ophthalmics
  71. Balance Digital Media Studios 
  72. Bannerflow
  73. Bausch Health 
  74. Bavarian Nordic
  75. Bayer
  76. BeiGene
  77. InnoCare Pharma
  78. Bellerophon Therapeutics 
  79. Bellicum Pharmaceuticals
  80. BenHealth Biopharmaceutical
  81. BerGenBio
  82. Betta Pharmaceuticals
  83. BIOCAD
  84. Biofabri
  85. Biogen
  86. Biohaven Pharmaceuticals
  87. BioLite
  88. BioMarin Pharmaceutical
  89. BioMimetix
  90. BioNTech
  91. Blue Earth Diagnostics
  92. Blueprint Medicines
  93. Boehringer Ingelheim
  94. Boston Biomedical
  95. Bracco Diagnostics
  96. Breath of Life International Pharma
  97. BrickSimple 
  98. Bristol-Myers Squibb
  99. Calithera Biosciences
  100. Cancer Insight
  101. Canopy Health Innovations
  102. CAS Lamvac Biotech
  103. Catalysis
  104. CCH Marketing
  105. Celgene
  106. Celldex Therapeutics
  107. CG Life 
  108. ChemoCentryx
  109. Chiesi Farmaceutici
  110. Chipscreen Biosciences
  111. Chong Kun Dang Pharmaceutical
  112. Chongqing Precision Biotech
  113. CHRP-India
  114. CitrusBits
  115. Clavax 
  116. Clene Nanomedicine
  117. Clevbrain Technologies
  118. Clinical Trial Center North
  119. Clovis Oncology
  120. Codebrik 
  121. Collaborative Medicinal Development 
  122. Complexa
  123. Concert Pharmaceuticals
  124. Constellation Pharmaceuticals
  125. Corcept Therapeutics
  126. Corvecto
  127. Cosmo Pharmaceuticals
  128. Covance
  129. Cramer
  130. Creatinno Tech
  131. Creative Hub
  132. Cree 
  133. Crinetics Pharmaceuticals
  134. CRISPR Therapeutics
  135. Crownpeak Partner Network
  136. CSL Behring
  137. CSPC Ouyi Pharmaceutical
  138. CSPC ZhongQi Pharmaceutical Technology
  139. CStone Pharmaceuticals
  140. CTI BioPharma
  141. CTI Clinical Trial and Consulting Services
  142. Chia Tai Tianqing Pharmaceutical
  143. CubeZoo 
  144. Cumberland Pharmaceuticals
  145. Custom Learning Designs
  146. Cygnet Infotech
  147. CytomX Therapeutics
  148. Da Vinci Media Production House 
  149. Daiichi Sankyo
  150. Dascena
  151. data.world
  152. DealTech
  153. Debiopharm International
  154. Diamyd Medical
  155. Digital Glare
  156. Digital Jalebi 
  157. Digital Media HQ
  158. DigiTrends
  159. Divison 6
  160. Divwy Technologies
  161. Dizal Pharmaceutical
  162. eFFECTOR Therapeutics
  163. Eisai
  164. Elevar Therapeutics
  165. Eli Lilly 
  166. Eloxx Pharmaceuticals
  167. EMD Serono
  168. EmeraMed
  169. Emergent BioSolutions
  170. Empathetic Media 
  171. EMS
  172. Endive Software
  173. Energenesis Biomedical
  174. Eon Reality
  175. Equations Digital
  176. Ethosh
  177. ExCellThera
  178. Exelixis
  179. ExpertsFromIndia
  180. Fake Production
  181. Ferring Pharmaceuticals
  182. FGK Clinical Research
  183. Fluper
  184. Focusteck
  185. Folio3
  186. FORMA Therapeutics
  187. Foundation Medicine
  188. Fulcrum Therapeutics
  189. G1 Therapeutics
  190. Galapagos
  191. Geekstack 
  192. Genentech
  193. General Electric
  194. GeneScience Pharmaceuticals
  195. Genesis Technologies
  196. Genexine
  197. Genmab
  198. Genor Biopharma
  199. Genuine
  200. Gilead Sciences
  201. GlaxoSmithKline
  202. Golden Biotechnology 
  203. Gossamer Bio
  204. Granzer Regulatory Consulting & Services
  205. Green Cross International
  206. Guangzhou Anjie Biomedical Technology
  207. Gwo Xi Stem Cell Applied Technology
  208. GWT-TUD
  209. Halozyme Therapeutics
  210. Hamilton Health Sciences
  211. Hanmi Pharmaceutical
  212. Health Decisions
  213. Helsinn Healthcare 
  214. Herantis Pharma
  215. Heron Therapeutics
  216. HighTide Biopharmaceutical
  217. Hope Biosciences
  218. Hope Infotech
  219. HQSoftware
  220. HTC
  221. HunterTech 
  222. Hutchison MediPharma 
  223. Hyperlink InfoSystem
  224. ibiixo Technologies
  225. Ichnos Sciences
  226. ILTOO Pharma
  227. I-Mab Biopharma 
  228. Imaginate 
  229. Imago BioSciences
  230. Immunitor
  231. Immunocore
  232. ImmunoGen
  233. Immunomedics
  234. IMV
  235. Immunovant 
  236. Impact XM
  237. In2Real
  238. Incyte
  239. Infinito VFX 
  240. InflaRx
  241. Innovent Biologics
  242. Inovio Pharmaceuticals
  243. INSYS Therapeutics 
  244. Intermind 
  245. IntraBio
  246. Invivo 
  247. IO Biotech
  248. iObeya 
  249. Ionis Pharmaceuticals
  250. Iovance Biotherapeutics
  251. Ipsen
  252. iQlance 
  253. IQVIA
  254. Irish Heart Foundation
  255. Janssen Pharmaceuticals
  256. Jash Entertainment
  257. Jazz Pharmaceuticals
  258. JCR Pharmaceuticals
  259. Jiangsu Alphamab Biopharmaceuticals
  260. Jiangsu Hengrui Medicine
  261. Johnson & Johnson
  262. JPLoft
  263. Julius Clinical
  264. Juno Therapeutics
  265. Kadmon
  266. Kanda 
  267. Kartos Therapeutics
  268. Karyopharm Therapeutics
  269. KENWAVES
  270. Kezar Life Sciences
  271. KGK Science
  272. Khora Virtual Reality 
  273. Kiniksa Pharmaceuticals
  274. Kissei Pharmaceutical
  275. Kwebmaker 
  276. Kyowa Kirin
  277. Laduma
  278. Lallemand Health Solutions
  279. LEAP 
  280. Leap Therapeutics
  281. Lee's Pharmaceutical
  282. leftchannel
  283. LEO Pharma
  284. LG Chem
  285. Longeveron
  286. LotzAp
  287. Loxo Oncology
  288. Luminary
  289. MacroGenics
  290. Mallinckrodt
  291. Marinus Pharmaceuticals
  292. Maruho
  293. Matterhorn
  294. Mayo Clinic
  295. McCann Health
  296. McDAY
  297. Media Horizon 
  298. MediciNova
  299. MedImmune
  300. MEDIPOST
  301. Medpace
  302. MedPacto
  303. MedSIR
  304. Medy-Tox
  305. MeiraGTx 
  306. Memat Digi 
  307. Merck
  308. Mereo BioPharma
  309. MFAR
  310. Microsoft
  311. Millennium Pharmaceuticals
  312. Miltenyi Biotec
  313. Mindgrub
  314. Mindtree 
  315. miRagen Therapeutics
  316. Mirati Therapeutics
  317. Mirum
  318. Miyens 
  319. mld digits 
  320. Moderna
  321. Momenta Pharmaceuticals
  322. MultiVir
  323. Mutual Mobile
  324. MV3 
  325. MyoKardia
  326. Nanopixel
  327. NanOlogy
  328. NantKwest
  329. Narola Infotech 
  330. NCodeTechnologies 
  331. Nektar Therapeutics
  332. Neurocrine Biosciences
  333. NeuroRx
  334. Newish Technology
  335. NEXT/NOW
  336. Nobelpharma
  337. Northwell Health
  338. Novartis
  339. Novo Nordisk
  340. Novocure
  341. NYU Langone Health
  342. OBI Pharma
  343. Oncoceutics
  344. Oncology Venture
  345. Oncopeptides
  346. OncoSec Medical
  347. OneProsper International
  348. Ono Pharmaceutical
  349. Oramed
  350. Orchard Therapeutics
  351. Orion
  352. Otsuka Pharmaceutical
  353. Ovid Therapeutics
  354. Panther Studio
  355. Parexel
  356. Peloton Therapeutics
  357. Pfizer
  358. Pharmacyclics
  359. PharmaMar
  360. PhaseBio Pharmaceuticals
  361. PhytoHealth 
  362. Pierre Fabre
  363. Pivotal
  364. PIXACORE
  365. Polygon Medical Animation
  366. PPD
  367. PRA Health Sciences
  368. Precision BioSciences
  369. PrECOG
  370. Preksh 
  371. Progenics Pharmaceuticals
  372. ProQR Therapeutics
  373. Protagonist Therapeutics
  374. Providence Health & Services
  375. PRP Concepts
  376. Pulmocide
  377. Pulmotect
  378. Puma Biotechnology
  379. Qilu Pharmaceutical
  380. Quast Media
  381. Ra Pharmaceuticals
  382. Random42 
  383. Reality Garage
  384. Red Apple Technologies
  385. RedRock Digimark
  386. Regeneron Pharmaceuticals
  387. REGENXBIO
  388. Reistone Biopharma
  389. RemeGen
  390. Revance Therapeutics
  391. RHEACELL
  392. Rhizen Pharmaceuticals
  393. Rhythm Pharmaceuticals
  394. Roche
  395. Rocket Pharmaceuticals
  396. R-Pharm
  397. Samsung Medical Center
  398. Samumed
  399. Sanaria
  400. Sangamo Therapeutics
  401. Sanofi
  402. Santen Pharmaceutical
  403. Sarepta Therapeutics
  404. Scientimed 
  405. Scintilla Kreations
  406. Sclnow Biotechnology
  407. SCRI Development Innovations
  408. Seattle Genetics
  409. Seehash Softwares
  410. SENSE-R 
  411. Service Monkey
  412. Servier
  413. Shenzhen BinDeBio
  414. Shionogi
  415. Shire
  416. Simulanis
  417. Sinocelltech
  418. SITSL
  419. SM Digital Partners
  420. SoftCover Virtual Reality
  421. Softweb Solutions
  422. Spectrum Pharmaceuticals
  423. Spring Bank Pharmaceuticals
  424. SpringWorks Therapeutics
  425. SSS International Clinical Research
  426. Stryker
  427. Studio 27 Creative Media Works
  428. Subvrsive
  429. Sun Pharma Advanced Research
  430. Sunovion
  431. Sunshine Lake Pharma
  432. Suzhou Zelgen Biopharmaceuticals
  433. SVAP Infotech
  434. Swedish Orphan Biovitrum
  435. Swiss Tomato
  436. Syndax Pharmaceuticals
  437. Syneos Health
  438. Syntax for Science
  439. TA Digital 
  440. Taiho Oncology
  441. Taiwan Liposome Company
  442. Takara Bio
  443. Takeda
  444. Talking Tree Creative 
  445. Target Health
  446. Teads 
  447. Tech Data
  448. Techno’s Tech Solutions
  449. TESARO
  450. TestByNet
  451. Teva Pharmaceuticals
  452. TG Therapeutics
  453. The Antialias
  454. The Emmes Company
  455. The Market Element
  456. The NineHertz 
  457. The Parallel
  458. Themis Bioscience
  459. Theradex Oncology
  460. Theravance Biopharma
  461. Thread Solutions 
  462. Tianhe Stem Cell Biotechnologies
  463. TICEBA
  464. Tilray
  465. Tipping Point Media
  466. Tolerion
  467. Tolero Pharmaceuticals
  468. Transgene
  469. Trium Analysis Online
  470. Trovagene
  471. Tufts Medical Center
  472. Turning Point Therapeutics
  473. TYME Technologies
  474. UCB
  475. Ultimate Medical Academy
  476. Ultragenyx Pharmaceutical
  477. University Medical Center  Utrecht
  478. Unanimity Information & Technology
  479. United BioPharma
  480. United Therapeutics
  481. University of Toronto
  482. US Biotest
  483. US WorldMeds
  484. Vaccitech 
  485. Variance InfoTech
  486. Vedanta Biosciences
  487. Verastem Oncology
  488. Vertex Pharmaceuticals
  489. Viela Bio
  490. ViitorCloud Technologies
  491. Virtual Reality Ireland 
  492. Viscira 
  493. Vistaar Digital Communications
  494. Visualise
  495. VR Vision 
  496. vStream 
  497. Warschawski 
  498. WebZino
  499. Weber Shandwick
  500. WETFY BRAND SOLUTIONS 
  501. WordPress
  502. Xeris Pharmaceuticals
  503. Xynomic Pharmaceuticals
  504. Y-mAbs Therapeutics
  505. YouVisit 
  506. Zai Lab
  507. Zumoko
  508. Zurich University of Applied Sciences
  509. Zydus Cadila

Request Customization

Please select a suitable option for customization in the report

PRICING DETAILS

USD 4,899

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print read more

This license grants the right of use of the purchased report by the employees of a business unit at a particular site / office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple read more

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm / enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the read more

Discounts available for multiple report purchases
sales@rootsanalysis.com